Literature DB >> 4979519

The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture.

A E Churchill, R C Chubb, W Baxendale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4979519     DOI： 10.1099/0022-1317-4-4-557

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


× No keyword cloud information.
  47 in total

1.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Studies of Marek's disease herpesvirus and turkey herpesvirus specific common antigen which stimulates the production of neutralizing antibodies.

Authors:  M Onuma; T Mikami; T T Hayashi; K Okada; Y Fujimoto
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

4.  Marek's Disease Herpesviruses I. Production and Preliminary Characterization of Marek's Disease Herpesvirus A Antigen.

Authors:  P A Long; P Kaveh-Yamini; L F Velicer
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

5.  Marek's disease--the disease and its prevention by vaccination.

Authors:  P M Biggs
Journal:  Br J Cancer Suppl       Date:  1975-03

6.  Revaccination with Marek's disease vaccines induces productive infection and superior immunity.

Authors:  Changxin Wu; Junji Gan; Qiao Jin; Chuangfu Chen; Ping Liang; Yantao Wu; Xuefen Liu; Li Ma; Fred Davison
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

7.  Gel electrophoretic analysis of polypeptides from nucleocapsids of Marek's disease virus strains and herpesvirus of turkey.

Authors:  F Westenbrink; J M Brinkhof; A L Gielkens
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  Comparison of the sequence of the secretory glycoprotein A (gA) gene in Md5 and BC-1 strains of Marek's disease virus type 1.

Authors:  T Ihara; A Kato; S Ueda; A Ishihama; K Hirai
Journal:  Virus Genes       Date:  1989-11       Impact factor: 2.332

9.  Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H.

Authors:  G Bradley; G Lancz; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Genetic relatedness of virulent and avirulent strains of Marek's disease virus.

Authors:  K Hirai; H Honma; K Ikuta; S Kato
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.